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Abstract
© 2018 Budak et al. This is an open access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original author and source are credited. Brucellosis is a serious
infectious disease that continues to be a significant cause of morbidity worldwide and across all
ages. Despite early diagnosis and treatment, 10±30% of patients develop chronic brucellosis.
Although there have been recent advances in our knowledge of Brucella virulence factors and
hosts'  immune response to the infection,  there is  a  lack of  clear  data regarding how the
infection bypasses the immune system and becomes chronic. The present study investigated
immunological factors and their roles in the transition of brucellosis from an acute to a chronic
infection in CD4+ T cells. CD4+ T cells sorted from peripheral blood samples of patients with
acute or chronic brucellosis and healthy controls using flow cytometry as well as more than
2000 miRNAs were screened using the GeneSpring GX (Agilent) 13.0 miRNA microarray software
and were validated using reverse transcription polymerase chain reaction (RT-qPCR). Compared
to acute cases, the expression levels of 28 miRNAs were significantly altered in chronic cases.
Apart from one miRNA (miR-4649-3p), 27 miRNAs were not expressed in the acute cases (p
<0.05, fold change> 2). According to KEGG pathway analysis, these miRNAs are involved in the
regulation  of  target  genes  that  were  previously  involved in  the  MAPK signalling  pathway,
regulation of the actin cytoskeleton, endocytosis, and protein processing in the endoplasmic
reticulum. This indicates the potential  role of these miRNAs in the development of chronic
brucellosis. We suggest that these miRNAs can be used as markers to determine the transition
of the disease into chronicity. This is the first study of miRNA expression that analyses human
CD4+ T cells to clarify the mechanism of chronicity in brucellosis.
http://dx.doi.org/10.1371/journal.pone.0198659
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